Best GLP-1 Telehealth Programs of 2026 [Ranked by Cost & Care]

Q: What happens when I want to come off GLP-1 medication?

A March 2026 systematic review in *eClinicalMedicine* found that patients regain roughly 60% of the weight they lost within a year of stopping GLP-1 therapy, with the steepest regain happening in the first few months rather than spread evenly over time. Calibrate is built around continuing coaching support at the same monthly rate even after your initial commitment ends, which suits patients tapering off medication. WeightWatchers Clinic and Found include taper planning in their standard wrap. B

Last updated: August 2026

Medical Disclaimer: This article is informational. Talk to a licensed clinician before starting, switching, or stopping any GLP-1 medication.

Affiliate Disclosure: Some links below may earn The GLP-1 Daily a commission at no extra cost to you. We rank programs on care quality first, price second.

Top GLP-1 Telehealth Programs at a Glance

Rank	Program	Monthly Cost	Best For	Verdict
1	WeightWatchers Clinic (Sequence)	$74-$149 + meds	Comorbidities	Most rigorous care
2	Found	$99 compounded / $650+ brand	Emotional eating	Best behavior coaching
3	MyStart Health	From $179 dose-locked	Experienced users	Cheapest legit price
4	Henry Meds	$197-$449	Compounded plus follow-up	Best compounded program
5	Eden	$119-$329	Switching flexibility	Most med options
6	Ro	$74-$149 + $149-$449 meds	Brand-name access	Cleanest UX
7	Hims	$149 + $249-$399 meds	Brand-name simplicity	Fully branded after Novo deal
8	Lemonaid	$49 + $229-$299	Tirzepatide focus	Lowest tirz pricing

Sources: each program's official pricing page, checked August 2026; KFF Health Tracking Poll.

In 2026, the GLP-1 telehealth market looks nothing like it did two years ago. About 12% of U.S. adults are currently taking a GLP-1 drug, and 18% say they've tried one at some point, according to KFF's Health Tracking Poll. Many of them start through an online program rather than a primary care visit — which is exactly why picking the right one matters.

That shift created a flood of providers — some excellent, some predatory. The FDA's 2024-2025 shortage resolutions forced every compounding-focused brand to retool, and a March 2026 patent settlement between Novo Nordisk and Hims reshaped the brand side of the market too.

I spent six weeks pulling pricing directly from each program's own site, calling intake lines, and cross-checking medical board and FDA regulatory filings. I also read patient-reported experiences on r/GLP1. What follows is the ranking I would hand my own family member.

What Makes a GLP-1 Telehealth Program Worth Paying For?

Most are not, honestly. The difference between a $99 and a $1,000+ program often has nothing to do with the medication itself. Compounded semaglutide from a 503A pharmacy and brand Wegovy use the same molecule.

What you pay for is the wrapper. Clinician hours, lab work, coaching, pharmacy reliability, and the off-ramp when something goes wrong matter most.

Structured behavioral support alongside a GLP-1 — food logging, a dietitian, a coach who checks in — is consistently associated with better long-term outcomes in obesity-medicine research, even though medication does most of the heavy lifting on the scale. That's the real argument for paying more than the bargain-bin price.

The Four Pillars I Scored

Clinical oversight. A licensed clinician must review your intake and stay reachable for dose adjustments. Bots and "medical advisors" are not the same.
Pricing transparency. Programs that price-lock across dose escalations score higher than ones that bump you at maintenance dose. Watch for this trap especially as compounding options narrow and programs look for new margin.
Medication sourcing. Post-shortage, compounding is legal but narrower. I checked each program's disclosed pharmacy partner and payment model against current FDA compounding rules.
Care wrap. Lab orders, side-effect support, RD access, and a plan for what happens after goal weight. A surprising number of programs have no maintenance pathway.

Why "Cheapest" Is Not Always Best

If you have done a year on Wegovy through your PCP, a flat-rate compounded program is hard to beat. But if this is your first GLP-1, the extra coaching from Found or WeightWatchers Clinic pays itself back in fewer ER visits from mismanaged side effects.

The clearest evidence for why an exit plan matters: a March 2026 systematic review in eClinicalMedicine found patients regain roughly 60% of the weight they lost within a year of stopping GLP-1 therapy, with the fastest regain happening in the first few months. Programs that plan for that moment are worth the premium.

How Much Does a GLP-1 Telehealth Program Cost in 2026?

Pricing bifurcated sharply this year. Direct-to-consumer brand programs through Ro and Hims now run roughly $249-$449 a month for cash-pay Wegovy or Zepbound, on top of a $39-$149 monthly membership — far below the $1,000+ list price, thanks to manufacturer direct-pricing programs like NovoCare and LillyDirect that telehealth platforms plug into.

On the other end, compounded semaglutide through Henry Meds, Eden, and MyStart starts at $119-$299. The middle tier — Found and WeightWatchers Clinic — runs $74-$149 for the program alone, before medication.

The catch nobody talks about: even where coverage exists, it's under pressure. Mercer's 2026 employer survey found 49% of large employers (500+ workers) covered GLP-1s in 2025, up from 44% in 2024 — but 77% of those employers now call managing GLP-1 costs "extremely" or "very" important, 6% dropped coverage outright in 2026, and another 5% are considering dropping it for 2027. If your plan doesn't cover the medication for weight loss specifically — as opposed to diabetes — you are very likely paying cash.

Compounded vs Brand: the Real Price Gap

Tier	Medication	Monthly Cost	Coaching
Premium brand	Wegovy or Zepbound (cash-pay via Ro/Hims)	$249-$449	Optional
Mid + brand	Found or WW Clinic + brand medication	$749-$1,299	Full wrap
Mid + compounded	Found + compounded GLP-1	$99-$199	Full wrap
Budget compounded	MyStart, Henry Meds, Eden	$119-$399	Minimal
Bargain (avoid)	Unnamed pharmacy programs	$89-$149	None

Compounded semaglutide is not FDA-approved as a finished product; the active ingredient itself is. Since the FDA's 2024-2025 shortage determinations, compounding is legal only when a prescriber documents a patient-specific clinical need — bulk "copy compounding" of a drug that's no longer in shortage isn't permitted either way.

Watch for These Pricing Traps

Three structures dominate the market. Each has its own tells.

Flat-rate, dose-locked. One price regardless of dose. MyStart, Henry Meds, and Mochi do this. Best for the patient.
Dose-tiered. Price climbs as you titrate up. Some compounded tirzepatide programs go from $229 to $299 as your dose rises. Penalizes responders.
Membership plus medication. Found charges a flat compounded rate but bills brand medication on top. Transparent if you read carefully.

Watch for non-refundable consultation fees, mandatory multi-month commitments, and "shipping fees" that add $40-$60 a month.

Top GLP-1 Telehealth Programs Ranked

I ranked these on clinical oversight (35%), price transparency (20%), medication sourcing (25%), and care wrap (20%). All pricing is current as of August 2026, pulled directly from each company's own pricing page. For a head-to-head on the three most-searched names, see our Hims vs Ro vs Found breakdown.

1. WeightWatchers Clinic (formerly Sequence) — Best Overall

Monthly cost: $25/month for the first 3 months on a 12-month plan (then $74/month for the rest of the commitment), or $149/month month-to-month, plus medication Coaching: Registered dietitian, behavior coach, weekly check-ins

Sequence was acquired by WeightWatchers in 2024 and has since been folded fully into the WeightWatchers Clinic brand. It remains the most clinically rigorous program I evaluated. Every patient gets a baseline metabolic panel, thyroid check, and kidney function screen, and the clinician network includes both MD/DOs and NPs board-certified in obesity or internal medicine.

The catch is the 12-month commitment — you can't cancel early even if you stop using the program, and medication (Wegovy, Saxenda, or Zepbound) is billed separately from the program fee.

Best for: Patients with comorbidities who need real medical supervision and don't mind locking in for a year.

2. Found — Best Behavior Coaching

Monthly cost: $99/month flat for compounded GLP-1s (price-locked across doses); brand Wegovy/Zepbound from $650+/month, Ozempic/Mounjaro around $1,100/month Coaching: Group and 1:1, RD access, mental health screening

Found's standout feature is its mental health intake. The program screens every patient for binge eating and disordered eating patterns before prescribing — a real gap in this market. A 2026 NEJM Perspective piece flagged this directly: clinicians are prescribing GLP-1s to patients with an undiagnosed eating disorder, and no national guideline requires screening for one first. Found is one of the few programs that does it up front.

Found also has a flexible medication menu and works with insurance for clinical visits, with most members paying under $30 per visit; it also runs a $50/month Medicare GLP-1 Bridge option for beneficiaries.

Best for: Patients who suspect emotional eating, or who have failed previous medication-only programs.

3. MyStart Health — Cheapest Legitimate Program

Monthly cost: From $179/month for semaglutide; tirzepatide from $279-$349/month Coaching: Minimal; clinician available for dose questions

MyStart's price-lock is the killer feature. You pay the same flat rate from starter dose through maintenance — no tier creep, no surprise upcharges. The network gives patients access to more than 600 board-certified providers, and no insurance is required.

MyStart discloses its compounding pharmacy is a Texas-licensed 503A facility. Before enrolling anywhere, confirm current inspection status yourself on the FDA's public inspection classification database — it's searchable by facility name.

What you give up: no behavior coaching, no included labs, and a lighter clinician-to-patient touch than premium programs.

Best for: Experienced GLP-1 users who know their dose and want to minimize cost.

4. Henry Meds — Best Compounded Program

Monthly cost: Semaglutide $297/month month-to-month ($247/month on a 6-month prepay, $197/month prepaid-in-full for 12 months); tirzepatide $349-$449/month, sold as a 3-month oral-tablet supply Coaching: Clinician follow-up at 30 and 60 days, then quarterly

Henry Meds was one of the first compounded-GLP-1 programs to hit scale and used the post-shortage period to professionalize, disclosing pharmacy partners on its site. One important change: as of mid-2026, Henry Meds offers tirzepatide only as dissolving oral tablets — there is no injectable tirzepatide option anymore. Henry Meds does not accept insurance.

Clinician follow-up cadence is the best in the compounded-only segment.

Best for: Patients who want more clinician contact than MyStart and are comfortable with oral tirzepatide.

5. Eden — Most Flexible Compounded Options

Monthly cost: Compounded semaglutide from $119/month; compounded tirzepatide from $229/month; flat, dose-independent pricing Coaching: Async messaging with clinician; no formal coaching

Eden offers both compounded and branded medications under one roof, plus quarterly refill scheduling. If you start on compounded and want to switch to a brand medication, you don't have to change programs. Eden has also expanded into anti-aging, hair growth, and mood-support services.

Best for: Patients who want to keep options open between compounded and brand-name.

6. Ro — Best Brand-Name Experience

Monthly cost: Membership $39 for month one, then $74-$149/month depending on prepay term; Wegovy pill $149-$299/month, Zepbound injection $299-$449/month Coaching: Care team access, no formal RD

Ro's cash-pay medication pricing is designed to match manufacturer direct programs — LillyDirect, NovoCare — and multi-month plans can cut costs further. The experience — onboarding, refill cadence, insurance navigation — is the cleanest in the category.

If your employer covers GLP-1s and you want a frictionless telehealth wrapper, Ro is hard to beat.

Best for: Patients who want the simplest path to brand-name Wegovy or Zepbound.

7. Hims (Hers) — Best for Branded-Only Simplicity

Monthly cost: Membership $39 for month one, then $149/month; Wegovy injectable $299/month, Wegovy oral $249/month, Zepbound $399/month, plus a $5 shipping fee Coaching: Limited

Hims' compounded-semaglutide era ended after a March 2026 patent-infringement settlement with Novo Nordisk. Hims wound the compounded product down and now prescribes only FDA-approved Novo Nordisk medications through its telehealth platform. If you were previously on Hims' compounded semaglutide, you've likely already been transitioned to a branded prescription or moved to a different program.

Best for: Patients who want a straightforward, brand-name-only telehealth wrapper.

8. Lemonaid Health — Best for Tirzepatide

Monthly cost: $49/month membership plus compounded tirzepatide at $299/month standard, $249/month (3-month prepay), or $229/month (6-month prepay); a lower-dose microdose option runs $199/month Coaching: Minimal

Lemonaid's tirzepatide pricing on longer commitments is among the more competitive verified prices in 2026, and HSA/FSA cards are accepted. For molecule comparison, see our semaglutide vs tirzepatide guide.

9. Calibrate — Best for Long-Term Coaching

Monthly cost: $199/month with a 3-month initial commitment ($597 total), continuing month-to-month at $199 after; or a $1,649 prepaid 12-month "Total Care" bundle Coaching: Heavy — RD, clinician, group coaching

Calibrate's model centers on year-long behavior-change coaching rather than just a prescription. With qualifying commercial insurance, GLP-1 copays are typically $25/month or less after any deductible, and the program includes a 10% weight-loss money-back guarantee. Coaching continues at the same $199/month rate even after your initial commitment ends, which is useful if you're tapering off medication and still want support.

10. Mochi Health — Best for Newcomers

Monthly cost: $79/month membership ($39 for month one), or $69/month on the Wellness Plus tier for patients with qualifying insurance; compounded medication billed separately at $99/month (semaglutide) or $199/month (tirzepatide) Coaching: Solid intake, lighter ongoing

Mochi gets new patients through onboarding faster than most, and membership fees are FSA/HSA eligible with no cancellation fees. The wrap thins out after month one. It's better as a starting point than a long-term home.

Are Compounded GLP-1 Programs Safe in 2026?

The short answer: yes, when sourced from a properly licensed 503A or 503B pharmacy that documents clinical need — and the rules keep getting tighter.

The FDA determined the tirzepatide (Mounjaro, Zepbound) shortage was resolved on December 19, 2024, and the semaglutide (Ozempic, Wegovy) shortage resolved on February 21, 2025. Compounders were given short enforcement-discretion windows to wind down emergency production — through spring 2025 for both drugs — before shortage-based compounding officially ended.

With the shortages over, compounding narrowed to cases with documented, patient-specific clinical justification. The FDA went further in 2026, proposing to formally exclude semaglutide, tirzepatide, and liraglutide from the list of substances 503B outsourcing facilities can compound in bulk — a public comment period on that proposal ran through June 29, 2026. If finalized, it would close off large-scale compounding almost entirely, leaving only narrow, patient-specific 503A compounding. Novo Nordisk's CEO estimated at the January 2026 J.P. Morgan Healthcare Conference that as many as 1.5 million Americans were still using compounded GLP-1s at that point.

See our deep-dive on the compounded GLP-1 crackdown for the regulatory background.

How to Vet Your Program's Pharmacy Partner

Before you send anyone $300, check three things:

The FDA inspection database. Search for the pharmacy by name. "No action indicated" is good. "Voluntary action indicated" is acceptable. "Official action indicated" is a red flag.
State board of pharmacy license. Confirm the pharmacy is licensed in your state.
The API source. Reputable compounding pharmacies source from FDA-registered manufacturers. Ask.

Best Program for Diabetes vs Weight Loss

These are different clinical populations with different insurance pictures. If you have type 2 diabetes, your medication is far more likely to be covered, and GLP-1s are established therapy for many patients.

If you are using GLP-1s for weight management without diabetes, you are probably paying cash. You need a program priced for that.

The ADA 2026 Standards of Care puts even more weight on choosing therapies with cardiometabolic benefit — GLP-1 RAs are now recommended for people with chronic kidney disease and for those with established or high-risk cardiovascular disease, independent of blood sugar control. The Standards also note that telehealth and remote coaching are reasonable options when in-person counseling isn't available.

For Patients with Comorbidities

Do not go cheap. Both ADA and cardiology guidance now recommend GLP-1 RAs for patients with established cardiovascular disease or heart failure alongside other guideline-directed therapy — which argues for programs with real MD/DO clinician oversight, like WeightWatchers Clinic, Found, or Calibrate, rather than a bargain-tier compounded plan with minimal follow-up. See our coverage of GLP-1s and heart attack recovery for the cardiac context.

Frequently Asked Questions

Are compounded GLP-1 programs still legal in 2026 after the FDA shortage ended?

Yes, but the rules keep tightening. Compounding under section 503A requires a patient-specific prescription with documented clinical need, and 503B outsourcing facilities can produce larger batches under direct FDA oversight — bulk "copy compounding" of a drug no longer in shortage isn't allowed under either pathway. In 2026 the FDA proposed formally excluding semaglutide, tirzepatide, and liraglutide from the 503B bulk-compounding list altogether, with a comment period that ran through June 29, 2026; if finalized, that would close off large-scale compounded production. Reputable programs disclose their pharmacy partner and document clinical rationale per patient. Bargain programs that don't are operating in a gray zone the FDA has signaled it will close.

Will my insurance cover a GLP-1 telehealth program in 2026?

More often for diabetes than for weight loss alone. Mercer's 2026 survey of large employers found 49% covered GLP-1s in 2025, up from 44% in 2024 — but cost pressure is now real: 6% of large employers dropped coverage in 2026 and another 5% are weighing it for 2027. Ro and Hims both offer insurance-navigation support for brand-name prescriptions, and Calibrate and Found will help you check what your plan covers before you commit. HSA and FSA dollars work for most programs even when insurance doesn't.

How much does a GLP-1 telehealth program cost out of pocket in 2026?

It depends on the medication and program. Compounded semaglutide runs roughly $99-$399 a month all-in — Found's flat $99/month compounded tier and MyStart's from-$179 price-locked plan are among the more transparent options. Branded medications (Wegovy, Zepbound) typically run $249-$449 a month through telehealth platforms like Ro and Hims in 2026, well below $1,000+ cash list prices, thanks to manufacturer direct-pricing programs. Mid-tier programs like Found and WeightWatchers Clinic add a membership fee on top of medication costs but include real coaching, RD access, and lab work.

How do I switch programs without losing my dose?

Request a complete medical record release before you cancel your current program, including dose history, lab work, and clinician notes. Most programs will release records within 7-14 days under HIPAA. Your new program's intake clinician can often continue your existing dose if you have documentation. Without it, they typically restart you at a lower dose for safety, and gaps of a few weeks are common when the paperwork isn't ready — so start the transfer before you cancel, not after.

What happens when I want to come off GLP-1 medication?

A March 2026 systematic review in eClinicalMedicine found that patients regain roughly 60% of the weight they lost within a year of stopping GLP-1 therapy, with the steepest regain happening in the first few months rather than spread evenly over time. Calibrate is built around continuing coaching support at the same monthly rate even after your initial commitment ends, which suits patients tapering off medication. WeightWatchers Clinic and Found include taper planning in their standard wrap. Bargain programs typically have no off-ramp — you just stop paying and stop getting medication, which is the worst way to come off a GLP-1.

My Bottom-Line Recommendations

If I were starting GLP-1 therapy for the first time today, I would go with WeightWatchers Clinic if I could handle the 12-month commitment and wanted the most clinical rigor, or Found if I suspected emotional eating was part of the picture and wanted the flexibility of month-to-month compounded pricing.

If I had done a year on a GLP-1 already and wanted cheap, dose-locked maintenance, MyStart Health from $179/month is the rational choice. If I had any cardiovascular history, I would skip the bargain tier entirely and pick a program with real MD/DO oversight.

Compounding access is likely to keep narrowing through 2026 and into 2027 as the FDA's 503B proposal works through the comment process, and brand pricing is unlikely to drop meaningfully until semaglutide's patents start expiring in the early 2030s. Pick the program that matches your medical complexity and your honest budget, and re-check pricing before you commit — this market moves fast.